<p>, /PRNewswire/ --</p>
<p>原因：罗森律师事务所是一家全球投资者权益法律事务所，宣布对 ADMA Biologics, Inc.（纳斯达克：ADMA）股东的潜在证券索赔进行调查，原因是有指控称 ADMA Biologics 可能向投资公众发布了重大误导性的商业信息。</p>
<p>那么：如果您购买了 ADMA Biologics 的证券，您可能有权在不支付任何自付费用或成本的情况下，通过风险收费安排获得赔偿。罗森律师事务所正在准备一项集体诉讼，寻求追回投资者损失。</p>
<p>接下来该怎么办：要加入潜在的集体诉讼，请访问 https://rosenlegal.com/submit-form/?case_id=57940 或拨打无障碍电话 866-767-3653 联系 Phillip Kim 律师，或发送电子邮件至 [email protected] 获取有关集体诉讼的信息。</p>
<p>这是什么：2026 年 3 月 24 日，Investing.com 发布了一篇题为&#34;ADMA Biologics 股价因做空者指控而暴跌&#34;的文章。文章指出，ADMA Biologics 的股价在&#34;做空者 Culper Research 发布报告指控该公司通过渠道填塞来夸大收入增长&#34;后下跌。</p>
<p>在这一消息影响下，ADMA Biologics 的股票在 2026 年 3 月 24 日下跌了 16.6%。</p>
<p>为什么选择罗森律师事务所：我们鼓励投资者选择在领导角色中有成功记录的合格律师事务所。通常，发布通知的事务所没有可比的经验、资源或任何有意义的同行认可。这些事务所中的许多实际上并不进行证券集体诉讼。在选择律师时要明智。罗森律师事务所代表全球投资者，专注于证券集体诉讼和股东衍生诉讼。罗森律师事务所曾在当时获得过针对中国公司的最大证券集体诉讼和解。在 2017 年，罗森律师事务所被 ISS 证券集体诉讼服务评为证券集体诉讼和解数量第一的事务所。自 2013 年以来，该事务所每年均排名前四，并为投资者追回了数亿美元。仅在 2019 年，该事务所就为投资者争取到了超过 4.38 亿美元的赔偿。在 2020 年，创始合伙人 Laurence Rosen 被 law360 评选为原告律师界的泰坦。该事务所的许多律师已获得 Lawdragon 和 Super Lawyers 的认可。</p>
<p>请在 LinkedIn 上关注我们以获取更新：https://www.linkedin.com/company/the-rosen-law-firm，在 Twitter 上：https://twitter.com/rosen_firm 或在 Facebook 上：https://www.facebook.com/rosenlawfirm/。</p>
<p>律师广告。之前的结果并不保证类似的结果。</p>
<p>联系信息：</p>
<p>Laurence Rosen，律师。</p>
<p>Phillip Kim，律师。</p>
<p>罗森律师事务所，P.A.。</p>
<p>275 Madison Avenue, 40th Floor</p>
<p>纽约，NY 10016</p>
<p>电话：（212）686-1060</p>
<p>免费电话：（866）767-3653</p>
<p>传真：（212）202-3827</p>
<p>[email protected]</p>
<p>www.rosenlegal.com</p>
<p>来源：罗森律师事务所，P.A.。</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTA4Jk5ld3NJdGVtSWQ9REM1NDc0MSZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MDgwMzE4UFJfTkVXU19VU1BSX19fX19EQzU0NzQx?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTA4Jk5ld3NJdGVtSWQ9REM1NDc0MSZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MDgwMzE4UFJfTkVXU19VU1BSX19fX19EQzU0NzQx"/></p>

ADMA生物制药

标普生物技术 ETF - SPDR

生物科技 ETF - VanEck Vectors

<p>罗斯律师事务所正在调查 ADMA Biologics, Inc.（纳斯达克代码：ADMA）股东的潜在证券索赔，原因是有关误导性商业信息的指控。购买 ADMA 证券的投资者可能有资格通过集体诉讼获得赔偿。此次调查是基于做空机构 Culper Research 的一份报告，该报告声称 ADMA 参与了渠道填充，导致股价下跌 16.6%。有兴趣的投资者可以联系该事务所以获取有关加入集体诉讼的更多信息</p>

<p>, /PRNewswire/ --</p>
<div class="lb-trans"><p>, /PRNewswire/ --</p>
</div><p>Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA) resulting from allegations that ADMA Biologics may have issued materially misleading business information to the investing public.</p>
<div class="lb-trans"><p>原因：罗森律师事务所是一家全球投资者权益法律事务所，宣布对 ADMA Biologics, Inc.（纳斯达克：ADMA）股东的潜在证券索赔进行调查，原因是有指控称 ADMA Biologics 可能向投资公众发布了重大误导性的商业信息。</p>
</div><p>So What: If you purchased ADMA Biologics securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.</p>
<div class="lb-trans"><p>那么：如果您购买了 ADMA Biologics 的证券，您可能有权在不支付任何自付费用或成本的情况下，通过风险收费安排获得赔偿。罗森律师事务所正在准备一项集体诉讼，寻求追回投资者损失。</p>
</div><p>What to do next: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=57940 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.</p>
<div class="lb-trans"><p>接下来该怎么办：要加入潜在的集体诉讼，请访问 https://rosenlegal.com/submit-form/?case_id=57940 或拨打无障碍电话 866-767-3653 联系 Phillip Kim 律师，或发送电子邮件至 [email protected] 获取有关集体诉讼的信息。</p>
</div><p>What is this about: On March 24, 2026, Investing.com published an article entitled &#34;ADMA Biologics shares plunge on short seller allegations.&#34; The article stated that ADMA Biologics shares fell &#34;after short seller Culper Research released a report alleging the company engaged in channel stuffing to inflate revenue growth.&#34;</p>
<div class="lb-trans"><p>这是什么：2026 年 3 月 24 日，Investing.com 发布了一篇题为&#34;ADMA Biologics 股价因做空者指控而暴跌&#34;的文章。文章指出，ADMA Biologics 的股价在&#34;做空者 Culper Research 发布报告指控该公司通过渠道填塞来夸大收入增长&#34;后下跌。</p>
</div><p>On this news, ADMA Biologics stock fell 16.6% on March 24, 2026.</p>
<div class="lb-trans"><p>在这一消息影响下，ADMA Biologics 的股票在 2026 年 3 月 24 日下跌了 16.6%。</p>
</div><p>Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. At the time Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.</p>
<div class="lb-trans"><p>为什么选择罗森律师事务所：我们鼓励投资者选择在领导角色中有成功记录的合格律师事务所。通常，发布通知的事务所没有可比的经验、资源或任何有意义的同行认可。这些事务所中的许多实际上并不进行证券集体诉讼。在选择律师时要明智。罗森律师事务所代表全球投资者，专注于证券集体诉讼和股东衍生诉讼。罗森律师事务所曾在当时获得过针对中国公司的最大证券集体诉讼和解。在 2017 年，罗森律师事务所被 ISS 证券集体诉讼服务评为证券集体诉讼和解数量第一的事务所。自 2013 年以来，该事务所每年均排名前四，并为投资者追回了数亿美元。仅在 2019 年，该事务所就为投资者争取到了超过 4.38 亿美元的赔偿。在 2020 年，创始合伙人 Laurence Rosen 被 law360 评选为原告律师界的泰坦。该事务所的许多律师已获得 Lawdragon 和 Super Lawyers 的认可。</p>
</div><p>Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.</p>
<div class="lb-trans"><p>请在 LinkedIn 上关注我们以获取更新：https://www.linkedin.com/company/the-rosen-law-firm，在 Twitter 上：https://twitter.com/rosen_firm 或在 Facebook 上：https://www.facebook.com/rosenlawfirm/。</p>
</div><p>Attorney Advertising. Prior results do not guarantee a similar outcome.</p>
<div class="lb-trans"><p>律师广告。之前的结果并不保证类似的结果。</p>
</div><p>Contact Information:</p>
<div class="lb-trans"><p>联系信息：</p>
</div><p>Laurence Rosen, Esq.</p>
<div class="lb-trans"><p>Laurence Rosen，律师。</p>
</div><p>Phillip Kim, Esq.</p>
<div class="lb-trans"><p>Phillip Kim，律师。</p>
</div><p>The Rosen Law Firm, P.A.</p>
<div class="lb-trans"><p>罗森律师事务所，P.A.。</p>
</div><p>275 Madison Avenue, 40th Floor</p>
<div class="lb-trans"><p>275 Madison Avenue, 40th Floor</p>
</div><p>New York, NY 10016</p>
<div class="lb-trans"><p>纽约，NY 10016</p>
</div><p>Tel: (212) 686-1060</p>
<div class="lb-trans"><p>电话：（212）686-1060</p>
</div><p>Toll Free: (866) 767-3653</p>
<div class="lb-trans"><p>免费电话：（866）767-3653</p>
</div><p>Fax: (212) 202-3827</p>
<div class="lb-trans"><p>传真：（212）202-3827</p>
</div><p>[email protected]</p>
<div class="lb-trans"><p>[email protected]</p>
</div><p>www.rosenlegal.com</p>
<div class="lb-trans"><p>www.rosenlegal.com</p>
</div><p>SOURCE THE ROSEN LAW FIRM, P. A.</p>
<div class="lb-trans"><p>来源：罗森律师事务所，P.A.。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTA4Jk5ld3NJdGVtSWQ9REM1NDc0MSZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MDgwMzE4UFJfTkVXU19VU1BSX19fX19EQzU0NzQx" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=DC54741&amp;Transmission_Id=202605080318PR_NEWS_USPR_____DC54741&amp;DateId=20260508"/></p>

03:18 ETRosen Law Firm Encourages ADMA Biologics, Inc. Investors to Inquire About Securities Class Action Investigation - ADMA

prnewswire

动态生物技术与基因组 ETF - Invesco

Invesco Nasdaq Biotechnology ETF

美国制药 ETF - iShares

纽交所高增长板生物技术指数 ETF - First Trust

标普全球医疗股指数 ETF - iShares

2 倍做多纳斯达克生物技术 ETF - ProShares

纳斯达克生物科技指数 ETF - iShares Nasdaq

基因改革 ETF - ARK

医疗业 ETF - SPDR

医药突破 ETF - ALPS

标普生物技术 3 倍做多 - Direxion

医疗业 ETF - Vanguard

罗森律师事务所鼓励 ADMA 生物制药公司的投资者了解证券集体诉讼调查的相关信息 - ADMA